These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33308884)

  • 1. The variability of the electrocardiogram in Brugada syndrome: Implications for subcutaneous implantable cardioverter-defibrillator candidacy.
    Brugada P
    Rev Port Cardiol (Engl Ed); 2021 Jan; 40(1):39-40. PubMed ID: 33308884
    [No Abstract]   [Full Text] [Related]  

  • 2. T-wave oversensing during exercise one year after cardioverter defibrillator implantation for Brugada syndrome.
    Otmani A; Rey JL; Leborgne L
    Arch Cardiovasc Dis; 2008 Apr; 101(4):292-4. PubMed ID: 18654108
    [No Abstract]   [Full Text] [Related]  

  • 3. Pitfalls in electrogram interpretation: Subcutaneous cardioverter defibrillator malfunction in Brugada syndrome.
    Morani G; Bolzan B; Tomasi L; Tomei R; Vassanelli C
    Pacing Clin Electrophysiol; 2017 Oct; 40(10):1180-1183. PubMed ID: 28432805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
    Sacher F; Probst V; Maury P; Babuty D; Mansourati J; Komatsu Y; Marquie C; Rosa A; Diallo A; Cassagneau R; Loizeau C; Martins R; Field ME; Derval N; Miyazaki S; Denis A; Nogami A; Ritter P; Gourraud JB; Ploux S; Rollin A; Zemmoura A; Lamaison D; Bordachar P; Pierre B; Jaïs P; Pasquié JL; Hocini M; Legal F; Defaye P; Boveda S; Iesaka Y; Mabo P; Haïssaguerre M
    Circulation; 2013 Oct; 128(16):1739-47. PubMed ID: 23995538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shock efficacy of the entirely subcutaneous defibrillator for termination of spontaneous ventricular fibrillation in Brugada syndrome.
    De Maria E; Cappelli S; Cappato R
    Heart Rhythm; 2013 Dec; 10(12):1807-9. PubMed ID: 23933298
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of electrocardiogram screening during drug challenge test for the prediction of T-wave oversensing by a subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.
    Kamakura T; Wada M; Ishibashi K; Inoue YY; Miyamoto K; Okamura H; Nagase S; Noda T; Aiba T; Yasuda S; Kusano K
    Heart Vessels; 2017 Oct; 32(10):1277-1283. PubMed ID: 28523371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise stress test reveals ineligibility for subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.
    Tachibana M; Nishii N; Morita H; Nakagawa K; Watanabe A; Nakamura K; Ito H
    J Cardiovasc Electrophysiol; 2017 Dec; 28(12):1454-1459. PubMed ID: 28800177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brugada Syndrome and the Subcutaneous Implantable Cardioverter-Defibrillator.
    Olde Nordkamp LRA; Conte G; Rosenmöller BRAM; Warnaars JLF; Tan HL; Caputo ML; Regoli F; Moccetti T; Auricchio A; Knops RE; Wilde AAM
    J Am Coll Cardiol; 2016 Aug; 68(6):665-666. PubMed ID: 27491911
    [No Abstract]   [Full Text] [Related]  

  • 9. Inappropriate Shock Due to Air Entrapment in the Pocket of a Subcutaneous Implantable Cardioverter-defibrillator.
    Linhart M; Tolosana JM; Chipa F; Trucco E; Mont L
    Rev Esp Cardiol (Engl Ed); 2019 Jan; 72(1):79-81. PubMed ID: 29246807
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of Brugada Syndrome 2016: Should All High Risk Patients Receive an ICD? All High-Risk Patients Should Receive an Implantable Cardiac Defibrillator.
    Sieira J; Brugada P
    Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27906652
    [No Abstract]   [Full Text] [Related]  

  • 11. Near fatal ventricular fibrillation in Brugada syndrome despite presence of an implanted implantable cardioverter defibrillator.
    Belhassen B; Viskin S
    Can J Cardiol; 2014 Nov; 30(11):1460.e3-5. PubMed ID: 25240706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ajmaline infusion during automated screening in Brugada syndrome and spontaneous Type 1 electrocardiogram unmasks non-suitability for subcutaneous implantable cardioverter-defibrillator.
    Özkartal T; Auricchio A; Conte G
    Eur Heart J; 2019 Jun; 40(23):1888-1889. PubMed ID: 30793741
    [No Abstract]   [Full Text] [Related]  

  • 13. Implantable Cardioverter-Defibrillator Therapy in Brugada Syndrome: Looking for Light at the End of the Tunnel.
    Spears DA
    JACC Clin Electrophysiol; 2019 Feb; 5(2):149-151. PubMed ID: 30784683
    [No Abstract]   [Full Text] [Related]  

  • 14. Current review of Brugada syndrome: from epidemiology to treatment.
    Khan A; Mittal S; Sherrid MV
    Anadolu Kardiyol Derg; 2009 Dec; 9 Suppl 2():12-6. PubMed ID: 20089482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome.
    Bonny A; Tonet J; Fontaine G; Frank R
    Eur Heart J; 2007 Nov; 28(22):2819-20; author reply 2820-1. PubMed ID: 17951573
    [No Abstract]   [Full Text] [Related]  

  • 16. Ice vs. fire: cryoballoon ablation for the prevention of inappropriate implantable cardioverter-defibrillator shocks in a 14-year-old girl with Brugada syndrome.
    Conte G; Chierchia GB; Levinstein M; Brugada P
    Europace; 2013 Dec; 15(12):1804. PubMed ID: 23599168
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of Brugada Syndrome 2016: Should All High Risk Patients Receive an ICD? Alternatives to Implantable Cardiac Defibrillator Therapy for Brugada Syndrome.
    Belhassen B
    Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27906651
    [No Abstract]   [Full Text] [Related]  

  • 18. Brugada syndrome presenting as an "acute myocardial infarction".
    Gallahue FE; Uzgiris R; Burke R; Abrahams W
    J Emerg Med; 2009 Jul; 37(1):15-20. PubMed ID: 18403174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of an exercise test to enhance sensing vector assessment and prevent inadequate subcutaneous implantable cardioverter-defibrillator discharges.
    Świerżyńska E; Sterliński M; Syska P; Sadowski K; Szumowski Ł
    J Electrocardiol; 2021; 67():73-76. PubMed ID: 34090117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience.
    Conte G; Sieira J; Ciconte G; de Asmundis C; Chierchia GB; Baltogiannis G; Di Giovanni G; La Meir M; Wellens F; Czapla J; Wauters K; Levinstein M; Saitoh Y; Irfan G; Julià J; Pappaert G; Brugada P
    J Am Coll Cardiol; 2015 Mar; 65(9):879-88. PubMed ID: 25744005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.